Related Experiment Video
Updated: Jan 9, 2026
Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions
Published on: April 23, 2021
Cerebrovascular hemodynamics and cardiac biomarkers in multiple sclerosis: A case-control study
Iria López-Dequidt1, Eugenia Fernández-Mellid2, Eva Costa-Arpín3
1Neurology Department, University Clinical Hospital of La Coruña, A Coruña, Spain.
Insights
Multiple sclerosis (MS) patients exhibit altered cerebrovascular hemodynamics, indicated by higher internal carotid artery pulsatility index (ICA PI). Elevated NT-proBNP in secondary progressive MS suggests cardiac strain, highlighting vascular and cardiac involvement in MS.
Area of Science:
- Neurology
- Cardiology
- Vascular Medicine
Background:
- Multiple sclerosis (MS) is associated with reduced cerebral blood flow and increased cardiovascular disease burden.
- The vascular component and subclinical disease in MS require further characterization.
Purpose of the Study:
- To compare subclinical vascular disease and thrombophilia in individuals with MS versus healthy controls.
- To investigate potential associations between vascular/cardiac parameters and MS disease characteristics.
Main Methods:
- Cross-sectional study involving 60 MS patients and 60 controls.
- Utilized Doppler ultrasound, flow-mediated dilation, echocardiography, and laboratory tests (including NT-proBNP).
- Assessed thrombophilia and analyzed vascular/cardiac parameters against MS disease metrics.
Main Results:
- MS patients showed significantly higher internal carotid artery pulsatility index (ICA PI).
- No significant differences in carotid atherosclerosis, endothelial function, or thrombophilia were found.
- Elevated NT-proBNP levels were observed in secondary progressive MS (SPMS) compared to relapsing-remitting MS (RRMS).
Conclusions:
- Individuals with MS demonstrate altered cerebrovascular hemodynamics (higher ICA PI) independent of traditional risk factors.
- Elevated NT-proBNP in SPMS may indicate cardiac strain in advanced MS stages.
- Findings suggest vascular and cardiac involvement in MS, warranting further longitudinal research.
Introduction:
Cerebral blood flow is reduced in multiple sclerosis (MS), potentially due to a partially understood vascular component. Individuals with MS also have a higher cardiovascular disease burden than the general population. We aimed to characterize and compare subclinical vascular disease and thrombophilia in individuals with MS versus healthy controls.
Methods:
In this cross-sectional study, 60 individuals with MS and 60 age-and sex-matched controls underwent clinical evaluation, carotid and transcranial Doppler ultrasound, brachial artery flow-mediated dilation (FMD), and transthoracic echocardiography (TTE) and laboratory testing, including N-terminal pro-B-type natriuretic peptide (NT-proBNP) measurement. Thrombophilia was assessed via laboratory testing for acquired coagulation disorders. Associations of vascular (ICA and MCA PI, RI, CIMT, FMD) and cardiac (NT-proBNP, LVEF) parameters with Expanded Disability Status Scale (EDSS), MS subtype, and disease duration were examined using correlation and regression analyses adjusted for age, sex, and vascular risk factors.
Results:
Individuals with MS showed significantly higher internal carotid artery pulsatility index (ICA PI ≥1.0; OR = 5.66, 95% CI 2.21-14.47, p < 0.001). No significant differences were observed in carotid atherosclerosis, endothelial function, or thrombophilia between groups. NT-proBNP levels were markedly higher in secondary progressive MS (SPMS) compared with relapsing-remitting MS (RRMS) (median [p25-p75]: 322 [188-396] vs. 49.5 [24.8-80.0] pg/mL, p = 0.025). No associations were found between vascular or cardiac parameters and disease duration and EDSS.
Conclusions:
Individuals with MS exhibit higher ICA PI compared with healthy controls, suggesting subtle subclinical alterations in cerebrovascular hemodynamics independent of traditional vascular risk factors or treatment status. Elevated NT-proBNP in SPMS may indicate mild cardiac strain associated with advanced disease stages. While these findings support the presence of vascular and cardiac involvement in MS, longitudinal studies are warranted to clarify causality and their potential role as biomarkers of disease progression.
Related Concept Videos
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...